RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund I Cap CHF/ LU1120849671 /
| NAV6/7/2024 | Chg.-0.4200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 85.5500CHF | -0.49% | reinvestment | Equity | FundPartner Sol.(EU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 6/11/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 2/26/2024 | Prospectus | 2024 | German | 1,165.74 KB |
| 2/19/2024 | PRIIP Key Information Document | 2024 | German | 108.23 KB |
| 12/31/2023 | Account statment | 2023 | German | 8,255.51 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 1,469.03 KB |
| 6/20/2022 | Key Investor Information | 2022 | German | 74.81 KB |
